Stay updated on M7824 and Eribulin in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.

Latest updates to the M7824 and Eribulin in Metastatic TNBC Clinical Trial page
- Check6 days agoChange DetectedThe page shows an updated revision number, changing from v3.6.2 to v3.6.3, indicating a small update to the page’s content or formatting. Core study details remain unchanged.SummaryDifference0.1%

- Check14 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, marking a new page version; this is a metadata update rather than a substantive change to the study data or content.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRecruitment is now marked as closed with 'No longer looking for participants'. In addition, navigation and heading labels were updated, including the replacement of 'Intervention / Treatment' with 'Intervention/Treatment', and new sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' were added, along with a revision tag updated to v3.6.0.SummaryDifference0.6%

- Check35 days agoChange DetectedUpdated the page revision from v3.5.4 to v3.5.5, reflecting a newer version of the study record.SummaryDifference0.1%

- Check57 days agoChange DetectedA new page revision, v3.5.4, was added and the previous revision v3.5.3 removed, signaling an update to the page's revision history.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page’s revision/version label in the footer was updated from v3.5.2 to v3.5.3, indicating a site release update rather than a change to the clinical trial information.SummaryDifference0.1%

Stay in the know with updates to M7824 and Eribulin in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the M7824 and Eribulin in Metastatic TNBC Clinical Trial page.